The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

The American Hospital Association is asking GE Healthcare to more fully apprise AHA’s nearly 5,000 member organizations of what the company is doing to help ameliorate the ongoing disruption in supplies of Omnipaque (iohexol).

U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.

With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have alluded that conservation efforts are of critical importance.

All formulations and concentrations of GE Healthcare’s Omnipaque (iohexol) are expected to be in short supply until mid-June due to COVID lockdowns where the contrast is manufactured.

Hospital and health systems saw incremental economic improvements in March, with rising margins and fewer COVID-19 cases and hospitalizations. 

Not all states are equal when it comes to the best places to work as a nurse.

The COVID-19 pandemic has left hospitals facing higher costs across the board, according to a recent report from the American Hospital Association (AHA).